Found: 493
Select item for more details and to access through your institution.
Unveiling new genetic insights in rheumatoid arthritis for drug discovery through Taxonomy3 analysis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64970-0
- By:
- Publication type:
- Article
Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 6, p. 1815, doi. 10.1007/s10067-024-06963-y
- By:
- Publication type:
- Article
Invariant Natural Killer T Cells Regulate Conventional Dendritic Cell Maturation to Re-establish Immune Tolerance to Rheumatoid Arthritis in DBA/1 Mice.
- Published in:
- Iranian Journal of Allergy, Asthma & Immunology, 2024, v. 23, n. 3, p. 299, doi. 10.18502/ijaai.v23i3.15639
- By:
- Publication type:
- Article
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 709, doi. 10.1007/s40744-024-00668-z
- By:
- Publication type:
- Article
Incidence Rates of Infections in Rheumatoid Arthritis Patients Treated with Janus Kinase or Interleukin-6 Inhibitors: Results of a Retrospective, Multicenter Cohort Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 10, p. 3000, doi. 10.3390/jcm13103000
- By:
- Publication type:
- Article
Mycosis fungoides‐like eruptions associated with abatacept.
- Published in:
- Australasian Journal of Dermatology, 2024, v. 65, n. 3, p. e77, doi. 10.1111/ajd.14249
- By:
- Publication type:
- Article
JAK2 inhibitors improve RA combined with pulmonary fibrosis in rats by downregulating SMAD3 phosphorylation.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 5, p. 1, doi. 10.1111/1756-185X.15164
- By:
- Publication type:
- Article
The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 9, p. 2517, doi. 10.3390/jcm13092517
- By:
- Publication type:
- Article
Association of Baseline Serum Soluble Tumour Necrosis Factor Receptor Levels with the Response of Rheumatoid Arthritis to Janus Kinase Inhibitor Therapy.
- Published in:
- International Journal of Rheumatology, 2024, v. 2024, p. 1, doi. 10.1155/2024/2898586
- By:
- Publication type:
- Article
Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 1, p. e247615, doi. 10.1001/jamanetworkopen.2024.7615
- By:
- Publication type:
- Article
Abatacept increases T cell exhaustion in early RA individuals who carry HLA risk alleles.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1383110
- By:
- Publication type:
- Article
Non-Invasive Assessment of Micro- and Macrovascular Function after Initiation of JAK Inhibitors in Patients with Rheumatoid Arthritis.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 8, p. 834, doi. 10.3390/diagnostics14080834
- By:
- Publication type:
- Article
Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 8, p. 2355, doi. 10.3390/jcm13082355
- By:
- Publication type:
- Article
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open‐Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 4, p. 541, doi. 10.1002/art.42752
- By:
- Publication type:
- Article
[<sup>18</sup>F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1297, doi. 10.1007/s00259-023-06557-x
- By:
- Publication type:
- Article
Long Non-Coding RNA AL928768.3 Promotes Rheumatoid Arthritis Fibroblast-Like Synoviocytes Proliferation, Invasion and Inflammation, While Inhibits Apoptosis Via Activating Lymphotoxin Beta Mediated NF-κB Signaling Pathway.
- Published in:
- Inflammation, 2024, v. 47, n. 2, p. 543, doi. 10.1007/s10753-023-01927-x
- By:
- Publication type:
- Article
Abatacept Could Prevent Progression to Rheumatoid Arthritis.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 11, p. 908, doi. 10.1001/jama.2024.1120
- By:
- Publication type:
- Article
Anticarcinogenic activity of Cl-Amidine on non-small cell lung cancer.
- Published in:
- Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2024, v. 41, n. 1, p. 80, doi. 10.52142/omujecm.41.1.13
- By:
- Publication type:
- Article
Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI)
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 2, p. 297, doi. 10.1093/mr/road045
- By:
- Publication type:
- Article
Correction to: Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI)
- Published in:
- 2024
- Publication type:
- Correction Notice
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients.
- Published in:
- Rheumatology, 2024, v. 63, n. 3, p. 725, doi. 10.1093/rheumatology/kead275
- By:
- Publication type:
- Article
Salidroside suppresses cell growth and inflammatory response of fibroblast-like synoviocytes via inhibition of phosphoinositol-3 kinase/threonine kinase signaling in rheumatoid arthritis.
- Published in:
- Zeitschrift für Rheumatologie, 2024, v. 83, p. 78, doi. 10.1007/s00393-023-01431-5
- By:
- Publication type:
- Article
Hunting uncertainties: JAK inhibitors and cancer risk.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 2, p. 1, doi. 10.1111/1756-185X.15070
- By:
- Publication type:
- Article
Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 2, p. 248, doi. 10.3390/ph17020248
- By:
- Publication type:
- Article
Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics.
- Published in:
- Rheumatology, 2024, v. 63, n. 2, p. 542, doi. 10.1093/rheumatology/kead260
- By:
- Publication type:
- Article
Establishment of a measurement system to evaluate breast milk transfer of biological agents using dry filter paper: A multi‐institutional study.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 1, p. 146, doi. 10.1111/bcp.15876
- By:
- Publication type:
- Article
Definition of follicular helper T cell and cytokines expression in synovial fluid of rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 1, p. 129, doi. 10.1007/s10067-023-06772-9
- By:
- Publication type:
- Article
A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 24, p. 2808, doi. 10.3390/cells12242808
- By:
- Publication type:
- Article
Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 12, p. 3225, doi. 10.1007/s10067-023-06787-2
- By:
- Publication type:
- Article
AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2494, doi. 10.1111/cts.13624
- By:
- Publication type:
- Article
Increased gene expression of CCR6 and RORγt in peripheral blood cells of rheumatoid arthritis patients and their correlation with anti‐cyclic citrullinated peptide and disease activity.
- Published in:
- Immunity, Inflammation & Disease, 2023, v. 11, n. 12, p. 1, doi. 10.1002/iid3.1112
- By:
- Publication type:
- Article
Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study.
- Published in:
- National Journal of Physiology, Pharmacy & Pharmacology, 2023, v. 13, n. 12, p. 2496, doi. 10.5455/njppp.2023.13.10511202306112023
- By:
- Publication type:
- Article
Effects of Abatacept in Patients with Rheumatoid Arthritis and Cancer Risk: A Systematic Review.
- Published in:
- Reviews in Clinical Medicine, 2023, v. 10, n. 4, p. 21
- By:
- Publication type:
- Article
Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1417, doi. 10.1007/s40744-023-00591-9
- By:
- Publication type:
- Article
Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational Study.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1753, doi. 10.1007/s40744-023-00609-2
- By:
- Publication type:
- Article
Experience with abatacept in refractory lupus nephritis.
- Published in:
- Rheumatology International, 2023, v. 43, n. 12, p. 2319, doi. 10.1007/s00296-023-05389-0
- By:
- Publication type:
- Article
Real-world retention rates of biologics in patients with rheumatoid arthritis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48537-z
- By:
- Publication type:
- Article
Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42324-6
- By:
- Publication type:
- Article
Association of Tumor Necrosis Factor Inhibitors with the Risk of Nontuberculous Mycobacterial Infection in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 22, p. 6998, doi. 10.3390/jcm12226998
- By:
- Publication type:
- Article
Alopecia Areata: Current Treatments and New Directions.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 6, p. 895, doi. 10.1007/s40257-023-00808-1
- By:
- Publication type:
- Article
Long‐Term Maintenance of Clinical Responses by Individual Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Abatacept.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 11, p. 2259, doi. 10.1002/acr.25156
- By:
- Publication type:
- Article
Efficacy and safety of novel biologics in the treatment of lupus nephritis based on registered clinical trials: a systematic review and network meta-analysis.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 7, p. 3011, doi. 10.1007/s10238-023-01132-y
- By:
- Publication type:
- Article
IL-6-induced response of human osteoblasts from patients with rheumatoid arthritis after inhibition of the signaling pathway.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 7, p. 3479, doi. 10.1007/s10238-023-01103-3
- By:
- Publication type:
- Article
The Effect of Leflunomide as Adjunctive Therapy With a TNF Inhibitor in Pediatric Patients With Uveitis.
- Published in:
- Journal of Pediatric Ophthalmology & Strabismus, 2023, v. 60, n. 6, p. 417, doi. 10.3928/01913913-20221118-03
- By:
- Publication type:
- Article
Causality assessment of adverse drug reaction reported in patients treated with arthritis in a tertiary care hospital: A prospective study.
- Published in:
- National Journal of Physiology, Pharmacy & Pharmacology, 2023, v. 13, n. 11, p. 2299, doi. 10.5455/njppp.2023.13.10483202315102023
- By:
- Publication type:
- Article
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles.
- Published in:
- Rheumatology, 2023, v. 62, n. 11, p. 3672, doi. 10.1093/rheumatology/kead110
- By:
- Publication type:
- Article
Safety of JAK and IL-6 inhibitors in patients with rheumatoid arthritis: a multicenter cohort study.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1267749
- By:
- Publication type:
- Article
Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 5, p. 1335, doi. 10.1007/s40744-023-00583-9
- By:
- Publication type:
- Article
Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02918-9
- By:
- Publication type:
- Article
The impact of EMA recommendations on the reallife use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1225160
- By:
- Publication type:
- Article